 | • レポートコード：GIR-2104Z01190 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、アトバコン＆プログアニルのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アトバコン＆プログアニルの種類別市場規模（250 mg/100 mg、62.5mg/25mg）、用途別市場規模（成人、小児）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・アトバコン＆プログアニルの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GSK、Glenmark、Mylan Pharmaceuticals、Hetero ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：250 mg/100 mg、62.5mg/25mg ・用途別分析2016年-2026年：成人、小児 ・アトバコン＆プログアニルの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・アトバコン＆プログアニルのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・アトバコン＆プログアニルのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・アトバコン＆プログアニルの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・アトバコン＆プログアニルの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Atovaquone and Proguanil market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Atovaquone and Proguanil size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Atovaquone and Proguanil market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Atovaquone and Proguanil market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
250 mg/100 mg
62.5mg/25mg
Market segment by Application can be divided into
Adult
Paediatric
The key market players for global Atovaquone and Proguanil market are listed below:
GSK
Glenmark
Mylan Pharmaceuticals
Hetero
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Atovaquone and Proguanil Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Atovaquone and Proguanil Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 250 mg/100 mg
1.2.3 62.5mg/25mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Atovaquone and Proguanil Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Adult
1.3.3 Paediatric
1.4 Global Atovaquone and Proguanil Market Size & Forecast
1.4.1 Global Atovaquone and Proguanil Sales in Value (2016-2026))
1.4.2 Global Atovaquone and Proguanil Sales in Volume (2016-2026)
1.4.3 Global Atovaquone and Proguanil Price by Type (2016-2026) & (USD/Unit)
1.5 Global Atovaquone and Proguanil Production Capacity Analysis
1.5.1 Global Atovaquone and Proguanil Total Production Capacity (2016-2026)
1.5.2 Global Atovaquone and Proguanil Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Atovaquone and Proguanil Market Drivers
1.6.2 Atovaquone and Proguanil Market Restraints
1.6.3 Atovaquone and Proguanil Trends Analysis
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Atovaquone and Proguanil Product and Services
2.1.4 GSK Atovaquone and Proguanil Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Glenmark
2.2.1 Glenmark Details
2.2.2 Glenmark Major Business
2.2.3 Glenmark Atovaquone and Proguanil Product and Services
2.2.4 Glenmark Atovaquone and Proguanil Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Mylan Pharmaceuticals
2.3.1 Mylan Pharmaceuticals Details
2.3.2 Mylan Pharmaceuticals Major Business
2.3.3 Mylan Pharmaceuticals Atovaquone and Proguanil Product and Services
2.3.4 Mylan Pharmaceuticals Atovaquone and Proguanil Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Hetero
2.4.1 Hetero Details
2.4.2 Hetero Major Business
2.4.3 Hetero Atovaquone and Proguanil Product and Services
2.4.4 Hetero Atovaquone and Proguanil Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Atovaquone and Proguanil Sales by Manufacturer
3.1 Global Atovaquone and Proguanil Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Atovaquone and Proguanil Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Atovaquone and Proguanil
3.4 Market Concentration Rate
3.4.1 Top 3 Atovaquone and Proguanil Manufacturer Market Share
3.4.2 Top 6 Atovaquone and Proguanil Manufacturer Market Share
3.5 Global Atovaquone and Proguanil Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Atovaquone and Proguanil Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Atovaquone and Proguanil Market Size by Region
4.1.1 Global Atovaquone and Proguanil Sales in Volume by Region (2016-2026)
4.1.2 Global Atovaquone and Proguanil Revenue by Region (2016-2026)
4.2 North America Atovaquone and Proguanil Revenue (2016-2026)
4.3 Europe Atovaquone and Proguanil Revenue (2016-2026)
4.4 Asia-Pacific Atovaquone and Proguanil Revenue (2016-2026)
4.5 South America Atovaquone and Proguanil Revenue (2016-2026)
4.6 Middle East and Africa Atovaquone and Proguanil Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Atovaquone and Proguanil Sales in Volume by Type (2016-2026)
5.2 Global Atovaquone and Proguanil Revenue by Type (2016-2026)
5.3 Global Atovaquone and Proguanil Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Atovaquone and Proguanil Sales in Volume by Application (2016-2026)
6.2 Global Atovaquone and Proguanil Revenue by Application (2016-2026)
6.3 Global Atovaquone and Proguanil Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Atovaquone and Proguanil Sales by Type (2016-2026)
7.2 North America Atovaquone and Proguanil Sales by Application (2016-2026)
7.3 North America Atovaquone and Proguanil Market Size by Country
7.3.1 North America Atovaquone and Proguanil Sales in Volume by Country (2016-2026)
7.3.2 North America Atovaquone and Proguanil Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Atovaquone and Proguanil Sales by Type (2016-2026)
8.2 Europe Atovaquone and Proguanil Sales by Application (2016-2026)
8.3 Europe Atovaquone and Proguanil Market Size by Country
8.3.1 Europe Atovaquone and Proguanil Sales in Volume by Country (2016-2026)
8.3.2 Europe Atovaquone and Proguanil Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Atovaquone and Proguanil Sales by Type (2016-2026)
9.2 Asia-Pacific Atovaquone and Proguanil Sales by Application (2016-2026)
9.3 Asia-Pacific Atovaquone and Proguanil Market Size by Region
9.3.1 Asia-Pacific Atovaquone and Proguanil Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Atovaquone and Proguanil Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Atovaquone and Proguanil Sales by Type (2016-2026)
10.2 South America Atovaquone and Proguanil Sales by Application (2016-2026)
10.3 South America Atovaquone and Proguanil Market Size by Country
10.3.1 South America Atovaquone and Proguanil Sales in Volume by Country (2016-2026)
10.3.2 South America Atovaquone and Proguanil Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Atovaquone and Proguanil Sales by Type (2016-2026)
11.2 Middle East & Africa Atovaquone and Proguanil Sales by Application (2016-2026)
11.3 Middle East & Africa Atovaquone and Proguanil Market Size by Country
11.3.1 Middle East & Africa Atovaquone and Proguanil Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Atovaquone and Proguanil Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Atovaquone and Proguanil Typical Distributors
12.3 Atovaquone and Proguanil Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Atovaquone and Proguanil Revenue by Type, (USD Million), 2021-2026
Table 2. Global Atovaquone and Proguanil Revenue by Application, (USD Million), 2021-2026
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Atovaquone and Proguanil Product and Services
Table 6. GSK Atovaquone and Proguanil Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Glenmark Basic Information, Manufacturing Base and Competitors
Table 8. Glenmark Major Business
Table 9. Glenmark Atovaquone and Proguanil Product and Services
Table 10. Glenmark Atovaquone and Proguanil Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Mylan Pharmaceuticals Major Business
Table 13. Mylan Pharmaceuticals Atovaquone and Proguanil Product and Services
Table 14. Mylan Pharmaceuticals Atovaquone and Proguanil Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Hetero Basic Information, Manufacturing Base and Competitors
Table 16. Hetero Major Business
Table 17. Hetero Atovaquone and Proguanil Product and Services
Table 18. Hetero Atovaquone and Proguanil Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Global Atovaquone and Proguanil Sales by Manufacturer (2019-2021e) & (K Units)
Table 20. Global Atovaquone and Proguanil Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 21. Market Position of Manufacturers in Atovaquone and Proguanil, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 22. Global Atovaquone and Proguanil Production Capacity by Company, (K Units): 2020 VS 2021
Table 23. Head Office and Atovaquone and Proguanil Production Site of Key Manufacturer
Table 24. Global Atovaquone and Proguanil Sales by Region (2016-2021e) & (K Units)
Table 25. Global Atovaquone and Proguanil Sales by Region (2021-2026) & (K Units)
Table 26. Global Atovaquone and Proguanil Revenue by Region (2016-2021e) & (USD Million)
Table 27. Global Atovaquone and Proguanil Revenue by Region (2021-2026) & (USD Million)
Table 28. Global Atovaquone and Proguanil Sales by Type (2016-2021e) & (K Units)
Table 29. Global Atovaquone and Proguanil Sales by Type (2021-2026) & (K Units)
Table 30. Global Atovaquone and Proguanil Revenue by Type (2016-2021e) & (USD Million)
Table 31. Global Atovaquone and Proguanil Revenue by Type (2021-2026) & (USD Million)
Table 32. Global Atovaquone and Proguanil Price by Type (2016-2021e) & (USD/Unit)
Table 33. Global Atovaquone and Proguanil Price by Type (2021-2026) & (USD/Unit)
Table 34. Global Atovaquone and Proguanil Sales by Application (2016-2021e) & (K Units)
Table 35. Global Atovaquone and Proguanil Sales by Application (2021-2026) & (K Units)
Table 36. Global Atovaquone and Proguanil Revenue by Application (2016-2021e) & (USD Million)
Table 37. Global Atovaquone and Proguanil Revenue by Application (2021-2026) & (USD Million)
Table 38. Global Atovaquone and Proguanil Price by Application (2016-2021e) & (USD/Unit)
Table 39. Global Atovaquone and Proguanil Price by Application (2021-2026) & (USD/Unit)
Table 40. North America Atovaquone and Proguanil Sales by Country (2016-2021e) & (K Units)
Table 41. North America Atovaquone and Proguanil Sales by Country (2021-2026) & (K Units)
Table 42. North America Atovaquone and Proguanil Revenue by Country (2016-2021e) & (USD Million)
Table 43. North America Atovaquone and Proguanil Revenue by Country (2021-2026) & (USD Million)
Table 44. North America Atovaquone and Proguanil Sales by Type (2016-2021e) & (K Units)
Table 45. North America Atovaquone and Proguanil Sales by Type (2021-2026) & (K Units)
Table 46. North America Atovaquone and Proguanil Sales by Application (2016-2021e) & (K Units)
Table 47. North America Atovaquone and Proguanil Sales by Application (2021-2026) & (K Units)
Table 48. Europe Atovaquone and Proguanil Sales by Country (2016-2021e) & (K Units)
Table 49. Europe Atovaquone and Proguanil Sales by Country (2021-2026) & (K Units)
Table 50. Europe Atovaquone and Proguanil Revenue by Country (2016-2021e) & (USD Million)
Table 51. Europe Atovaquone and Proguanil Revenue by Country (2021-2026) & (USD Million)
Table 52. Europe Atovaquone and Proguanil Sales by Type (2016-2021e) & (K Units)
Table 53. Europe Atovaquone and Proguanil Sales by Type (2021-2026) & (K Units)
Table 54. Europe Atovaquone and Proguanil Sales by Application (2016-2021e) & (K Units)
Table 55. Europe Atovaquone and Proguanil Sales by Application (2021-2026) & (K Units)
Table 56. Asia-Pacific Atovaquone and Proguanil Sales by Region (2016-2021e) & (K Units)
Table 57. Asia-Pacific Atovaquone and Proguanil Sales by Region (2021-2026) & (K Units)
Table 58. Asia-Pacific Atovaquone and Proguanil Revenue by Region (2016-2021e) & (USD Million)
Table 59. Asia-Pacific Atovaquone and Proguanil Revenue by Region (2021-2026) & (USD Million)
Table 60. Asia-Pacific Atovaquone and Proguanil Sales by Type (2016-2021e) & (K Units)
Table 61. Asia-Pacific Atovaquone and Proguanil Sales by Type (2021-2026) & (K Units)
Table 62. Asia-Pacific Atovaquone and Proguanil Sales by Application (2016-2021e) & (K Units)
Table 63. Asia-Pacific Atovaquone and Proguanil Sales by Application (2021-2026) & (K Units)
Table 64. South America Atovaquone and Proguanil Sales by Country (2016-2021e) & (K Units)
Table 65. South America Atovaquone and Proguanil Sales by Country (2021-2026) & (K Units)
Table 66. South America Atovaquone and Proguanil Revenue by Country (2016-2021e) & (USD Million)
Table 67. South America Atovaquone and Proguanil Revenue by Country (2021-2026) & (USD Million)
Table 68. South America Atovaquone and Proguanil Sales by Type (2016-2021e) & (K Units)
Table 69. South America Atovaquone and Proguanil Sales by Type (2021-2026) & (K Units)
Table 70. South America Atovaquone and Proguanil Sales by Application (2016-2021e) & (K Units)
Table 71. South America Atovaquone and Proguanil Sales by Application (2021-2026) & (K Units)
Table 72. Middle East & Africa Atovaquone and Proguanil Sales by Country (2016-2021e) & (K Units)
Table 73. Middle East & Africa Atovaquone and Proguanil Sales by Country (2021-2026) & (K Units)
Table 74. Middle East & Africa Atovaquone and Proguanil Revenue by Country (2016-2021e) & (USD Million)
Table 75. Middle East & Africa Atovaquone and Proguanil Revenue by Country (2021-2026) & (USD Million)
Table 76. Middle East & Africa Atovaquone and Proguanil Sales by Type (2016-2021e) & (K Units)
Table 77. Middle East & Africa Atovaquone and Proguanil Sales by Type (2021-2026) & (K Units)
Table 78. Middle East & Africa Atovaquone and Proguanil Sales by Application (2016-2021e) & (K Units)
Table 79. Middle East & Africa Atovaquone and Proguanil Sales by Application (2021-2026) & (K Units)
Table 80. Direct Channel Pros & Cons
Table 81. Indirect Channel Pros & Cons
Table 82. Atovaquone and Proguanil Typical Distributors
Table 83. Atovaquone and Proguanil Typical Customers
List of Figures
Figure 1. Atovaquone and Proguanil Picture
Figure 2. Global Atovaquone and Proguanil Sales Market Share by Type in 2020
Figure 3. 250 mg/100 mg
Figure 4. 62.5mg/25mg
Figure 5. Global Atovaquone and Proguanil Sales Market Share by Application in 2020
Figure 6. Adult
Figure 7. Paediatric
Figure 8. Global Atovaquone and Proguanil Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Atovaquone and Proguanil Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Atovaquone and Proguanil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Atovaquone and Proguanil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Atovaquone and Proguanil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Atovaquone and Proguanil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Atovaquone and Proguanil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Atovaquone and Proguanil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Atovaquone and Proguanil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Atovaquone and Proguanil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Atovaquone and Proguanil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Atovaquone and Proguanil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Atovaquone and Proguanil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Atovaquone and Proguanil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Atovaquone and Proguanil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Atovaquone and Proguanil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Atovaquone and Proguanil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Atovaquone and Proguanil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Atovaquone and Proguanil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Atovaquone and Proguanil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Atovaquone and Proguanil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Atovaquone and Proguanil Sales (2016-2026) & (K Units)
Figure 30. Global Atovaquone and Proguanil Production Capacity (2016-2026) & (K Units)
Figure 31. Global Atovaquone and Proguanil Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Atovaquone and Proguanil Market Drivers
Figure 33. Atovaquone and Proguanil Market Restraints
Figure 34. Atovaquone and Proguanil Market Trends
Figure 35. Global Atovaquone and Proguanil Sales Market Share by Manufacturer in 2020
Figure 36. Global Atovaquone and Proguanil Revenue Market Share by Manufacturer in 2020
Figure 37. Atovaquone and Proguanil Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Atovaquone and Proguanil Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Atovaquone and Proguanil Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Atovaquone and Proguanil Sales Market Share by Region (2016-2026)
Figure 41. Global Atovaquone and Proguanil Revenue Market Share by Region (2016-2026)
Figure 42. North America Atovaquone and Proguanil Revenue (2016-2026) & (USD Million)
Figure 43. Europe Atovaquone and Proguanil Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Atovaquone and Proguanil Revenue (2016-2026) & (USD Million)
Figure 45. South America Atovaquone and Proguanil Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Atovaquone and Proguanil Revenue (2016-2026) & (USD Million)
Figure 47. Global Atovaquone and Proguanil Sales Market Share by Type (2016-2026)
Figure 48. Global Atovaquone and Proguanil Revenue Market Share by Type (2016-2026)
Figure 49. Global Atovaquone and Proguanil Price by Type (2016-2026) & (USD/Unit)
Figure 50. Global Atovaquone and Proguanil Sales Market Share by Application (2016-2026)
Figure 51. Global Atovaquone and Proguanil Revenue Market Share by Application (2016-2026)
Figure 52. Global Atovaquone and Proguanil Price by Application (2016-2026) & (USD/Unit)
Figure 53. North America Atovaquone and Proguanil Sales Market Share by Country (2016-2026)
Figure 54. North America Atovaquone and Proguanil Revenue Market Share by Country (2016-2026)
Figure 55. North America Atovaquone and Proguanil Sales Market Share by Type (2016-2026)
Figure 56. North America Atovaquone and Proguanil Sales Market Share by Application (2016-2026)
Figure 57. Europe Atovaquone and Proguanil Sales Market Share by Country (2016-2026)
Figure 58. Europe Atovaquone and Proguanil Revenue Market Share by Country (2016-2026)
Figure 59. Europe Atovaquone and Proguanil Sales Market Share by Type (2016-2026)
Figure 60. Europe Atovaquone and Proguanil Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Atovaquone and Proguanil Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Atovaquone and Proguanil Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Atovaquone and Proguanil Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Atovaquone and Proguanil Sales Market Share by Application (2016-2026)
Figure 65. South America Atovaquone and Proguanil Sales Market Share by Country (2016-2026)
Figure 66. South America Atovaquone and Proguanil Revenue Market Share by Country (2016-2026)
Figure 67. South America Atovaquone and Proguanil Sales Market Share by Type (2016-2026)
Figure 68. South America Atovaquone and Proguanil Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Atovaquone and Proguanil Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Atovaquone and Proguanil Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Atovaquone and Proguanil Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Atovaquone and Proguanil Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界のアトバコン市場 2021：企業別、地域別、種類・用途別 The Atovaquone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent …- 世界の小児用ワクチン市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Paediatric Vaccine Market The global Paediatric Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes…
- 世界の小児用ワクチン市場 2021：企業別、地域別、種類・用途別 The Paediatric Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 世界のアダルトストア市場規模・現状・予測（2021年-2027年） Adult Stores sell various products such as couples toys, bullet vibrators, condoms, personal lubricants, erotic lingerie, and sexual enhancement supplements People around the globe, particularly in countries in the Americas and EMEA, are coming out to identify themselves as a part of the lesbian, ga…
- 世界の大人用冷えピタ市場 2021：企業別、地域別、種類・用途別 The Adult Cooling Sheet market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…